In the news
See our latest media coverage
We’re thrilled to share our knowledge and solutions with the world through interviews, articles, podcasts and more. If you are a member of the media and are interested in an interview, please contact us below.
Predictive Oncology in the news


Predictive Oncology has an AI-driven drug discovery platform to improve cancer treatments and speed up drug development
Proactive
The company is set to be a first mover in the artificial intelligence powered drug discovery market that will grow to $20 billion in the next three years


Using artificial intelligence to find the next cancer drug
CheckRare
Pamela Bush, PhD, of Predictive Oncology talks to CheckRare about the company’s technology to use artificial intelligence (AI) to develop cancer medications.
News & resources
Dominic Pollard of Cancer Research Horizons and Dr. Pamela Bush of Predictive Oncology discuss the potential impact of their collaboration and how it can advance...
Cancer Research Horizons to incorporate PEDAL into future drug discovery processes to enable drug development on a global scale 11 marketed drugs 2nd largest oncology...
Proactive Investor’s Natalie Stoberman met with Raymond F. Vennare, CEO of Predictive Oncology, and Javier Torres-Roca, MD, Co-Founder and CEO of Cvergenx, Inc., to discuss...